Holen Sie sich die Stockscreener-App
110.90
5.19%
8.225
Schlusskurs vom Vortag:
$102.67
Offen:
$105.13
24-Stunden-Volumen:
94,473
Relative Volume:
1.80
Marktkapitalisierung:
$4.92B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-17.04%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$104.03
$118.00
1-Wochen-Bereich:
$99.47
$130.00
52-Wochen-Spanne:
$88.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Firmenname
Billiontoone Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BLLN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
108.36 | 4.72B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
570.68 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
225.65 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.00 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.44 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
223.25 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-01 | Eingeleitet | BTIG Research | Buy |
| 2025-12-01 | Eingeleitet | JP Morgan | Overweight |
| 2025-12-01 | Eingeleitet | Jefferies | Hold |
| 2025-12-01 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-01 | Eingeleitet | Stifel | Buy |
| 2025-12-01 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-12-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Billiontoone Inc Aktie (BLLN) Neueste Nachrichten
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - The Manila Times
BillionToOne (NASDAQ: BLLN) schedules Q3 2025 results and call for Dec. 9, 2025 - Stock Titan
Billiontoone (NASDAQ:BLLN) Coverage Initiated by Analysts at JPMorgan Chase & Co. - Defense World
Piper Sandler initiates BillionToOne stock coverage with Overweight rating By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Overweight by JPMorgan on diagnostic tech - Investing.com Canada
BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - whbl.com
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth - Investing.com Nigeria
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth By Investing.com - Investing.com South Africa
BillionToOne Analysts Praise Molecular Diagnostic Firm's IPO RallyBillionToOne (NASDAQ:BLLN) - Benzinga
BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution - Investing.com Canada
BillionToOne Shares Fall After Jefferies Initiates Coverage at Hold - marketscreener.com
BillionToOne initiated with an Outperform at William Blair - TipRanks
BillionToOne stock initiated at Equal Weight by Wells Fargo with $110 target - Investing.com South Africa
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
Stifel Initiates BillionToOne at Buy With $145 Price Target - marketscreener.com
Piper Sandler Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
JPMorgan Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
Wells Fargo Initiates BillionToOne at Equalweight With $110 Price Target - MarketScreener
William Blair Initiates BillionToOne at Outperform - MarketScreener
BTIG Initiates BillionToOne at Buy With $160 Price Target - marketscreener.com
BillionToOne’s Hot IPO Has Analysts Onboard Early - Finimize
BillionToOne: Disrupting Diagnostics with Groundbreaking Tech - Devdiscourse
William Blair initiates coverage on BillionToOne stock with Outperform rating By Investing.com - Investing.com South Africa
BillionToOne initiated with an Equal Weight at Wells Fargo - TipRanks
William Blair initiates coverage on BillionToOne stock with Outperform rating - Investing.com
BillionToOne: A High-Growth Leader in Prenatal Genetics and Oncology with Strong Buy Rating - TipRanks
BillionToOne initiated with a Hold at Jefferies - TipRanks
BillionToOne initiated with an Overweight at Piper Sandler - TipRanks
Jefferies initiates BillionToOne stock with Hold rating, $117 price target By Investing.com - Investing.com Australia
BillionToOne initiated with a Buy at Stifel - TipRanks
BillionToOne’s Innovative Platform Poised for Growth in Reproductive Health and Oncology Markets - TipRanks
BillionToOne’s Innovative Sequencing Platform and Strong Growth Prospects Justify Buy Rating and $150 Price Target - TipRanks
BillionToOne initiated with an Overweight at JPMorgan - TipRanks
Balanced Outlook on BillionToOne, Inc.: High Growth Potential Amidst Competitive Challenges - TipRanks
BillionToOne, Inc.: Strong Market Position and Profitability Justify Buy Rating - TipRanks
Piper Sandler initiates BillionToOne stock coverage with Overweight rating - Investing.com India
Jefferies initiates BillionToOne stock with Hold rating, $117 price target - Investing.com
BillionToOne stock initiated with Buy rating at Stifel on NIPT market share gains - Investing.com India
BillionToOne stock initiated with Buy rating at Stifel on NIPT market share gains By Investing.com - Investing.com South Africa
BLLNBilliontoone Inc Stock Price and Quote - Finviz
BillionToOne, Inc. (BLLN) stock major holders - Yahoo Finance Australia
BillionToOne, Inc. (BLLN) Stock Major Holders - Yahoo! Finance Canada
IPO Stock Taps Massive Medicare Market, Soars Into Buy Range - Investor's Business Daily
BillionToOne, Inc. (BLLN) Beta - Zacks Investment Research
BLLN Stock Today: BillionToOne Closes Near Highs as Post‑IPO Rally Accelerates (Nov. 24, 2025) - ts2.tech
BillionToOne, Inc. (BLLN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Finanzdaten der Billiontoone Inc-Aktie (BLLN)
Es liegen keine Finanzdaten für Billiontoone Inc (BLLN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):